RAC 2.92% $1.94 race oncology ltd

Ann: Race Leadership Changes, page-415

  1. 441 Posts.
    lightbulb Created with Sketch. 674
    I don't want a phone call from DCB. An email that "gets" the concern will be more than sufficient.

    I do also want a General Meeting to update shareholders on the status of the business' three areas of focus, and a commitment from the BOD to uphold the commitment to wide shareholder interests. Whether that happens is again up to the BOD.

    For the record, absolutely believe the fundamentals have only improved for Zantrene - and my concerns now stem from realising that potential as fully as possible.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.